Voting open for Clinical Vice President (Medical)

10 September 2026
Voting is now open for the UKKA Clinical Vice President (Medical) election. This important leadership role represents the medical voice within the Association and contributes to the UKKA’s strategic direction. The Clinical Vice President (Medical) sits on the UKKA Trustee Board and works closely...
Read more

ANN UK officially joins the UKKA

9 September 2026
The Association of Nephrology Nurses UK (ANN UK) has officially become a professional group of the UK Kidney Association, effective from 7 September 2026. The move brings ANN UK and the UKKA together within one professional association, creating a stronger, more connected multiprofessional community...
Read more

The MHRA Suspends Avacopan for New Patients

2 September 2026
Following review, the MHRA has concluded that the available evidence no longer supports a positive benefit-risk balance for Avacopan Vifor (previously known as Tavneos), used in combination with rituximab or cyclophosphamide for adults with severe, active granulomatosis with polyangiitis (GPA) or...
Read more

Transforming community voices into national action

12 August 2026
Over the past 6 months, the kidney community has been campaigning to policymakers for a Kidney Disease Modern Service Framework. October 2025 - open letter calling for a national kidney disease strategy delivered to Prime Minister with over 13,000 signatures February – March 2026 – campaign action...
Read more

Trainee Opportunity: 'Writing to Kidney Patients' Project

4 August 2026
We are seeking a renal trainee to join the UKKA 'Writing to Kidney Patients' project, which aims to develop national, co-produced resources to make kidney clinic communication genuinely patient-centred rather than clinician- or GP-directed. This is an opportunity for a trainee interested in shared...
Read more

Updated: Home Dialysis Utility Reimbursement Calculator (2026)

30 July 2026
The latest version of the Home Dialysis Utility Reimbursement Calculator is now available, reflecting utility tariffs for July 2026 to March 2027. Developed by the Welsh Kidney Network (WKN) in collaboration with the UK Kidney Association (UKKA) and ANNUK, the calculator helps kidney teams...
Read more

UKKA calls for flexible approach to rare disease therapies

29 July 2026
The UK Kidney Association (UKKA) and the British Association for Paediatric Nephrology (BAPN) have submitted a joint response to the Medicines and Healthcare products Regulatory Agency (MHRA) consultation on its proposed Rare Disease Therapies Regulatory Framework , reflecting the views of the wider...
Read more

Avacopan update 24/07/26

27 July 2026
Vifor, which markets avacopan in the UK, has issued a safety communication, in agreement with the MHRA, advising that no new patients should be started on the medicine while the MHRA review is ongoing. Interim guidance pending the MHRA review Services and clinicians are asked to adopt the following...
Read more